Test Enhances Colon Cancer Treatment

OMAHA, Neb. -- A test that analyzes DNA mutations in tumors has reduced the amount hardship endured by colon cancer patients during treatment.
The test, known as KRAS, represents personalized medicine in the field of cancer treatment, said University of Nebraska Medical Center pathologist Timothy Greiner.

If a mutation is present, the test can help physicians determine what treatments will not work on a tumor. The most beneficial treatment can then be applied. Greiner said making such a determination will save a person time, money and pain by avoiding useless procedures.
Larry Worth said the treatment has made a significant impact on his life. Wirth was diagnosed in 2007 with colon cancer that had spread to his liver and lungs. He quickly had to focus on the most useful treatment.
Greiner said similar tests will eventually be available for every type of tumor.
Physicians recommend colon cancer screenings beginning at the age of 50 and earlier for those with family histories of the disease.
Copyright 2009 by KETV.com. All rights reserved. This material may not be published, broadcast, rewritten or redistributed